Neovascular macular degeneration Clinical Trials
Conditions / Neovascular macular degeneration
Delta Trials indexes 3 clinical trials for Neovascular macular degeneration in its publicly accessible dataset. Of these, 0 enrolling participants at this time and 3 trials have reached completion. This research takes place spanning 51 research sites around the world. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
3
Total Trials
0
Recruiting
3
Completed
0
Other Active
0
Terminated since 2020
51
Study Locations
Browse by location (51 total)
- Budapest, Hungary 1 trialAll trials in Budapest, Hungary
- Hirakata, Japan 1 trialAll trials in Hirakata, Japan
- Suita, Japan 1 trialAll trials in Suita, Japan
- Kumamoto, Japan 1 trialAll trials in Kumamoto, Japan
- Sapporo, Japan 1 trialAll trials in Sapporo, Japan
- Kaohsiung City, Taiwan 1 trialAll trials in Kaohsiung City, Taiwan
- Aomori, Japan 1 trialAll trials in Aomori, Japan
- Chiyoda-ku, Japan 1 trialAll trials in Chiyoda-ku, Japan
- Chiyoda-ku,, Japan 1 trialAll trials in Chiyoda-ku,, Japan
- Fukushima, Japan 1 trialAll trials in Fukushima, Japan
- East Melbourne, Australia 1 trialAll trials in East Melbourne, Australia
- Asahikawa, Japan 1 trialAll trials in Asahikawa, Japan
- Taipei, Taiwan 1 trialAll trials in Taipei, Taiwan
- Taipei, Taiwan 1 trialAll trials in Taipei, Taiwan
- Omaha, United States 1 trialAll trials in Omaha, United States
- Shinjuku-ku, Japan 1 trialAll trials in Shinjuku-ku, Japan
- Shinjuku- Ku, Japan 1 trialAll trials in Shinjuku- Ku, Japan
- Fukuoka, Japan 1 trialAll trials in Fukuoka, Japan
- Akita, Japan 1 trialAll trials in Akita, Japan
- Hamamatsu, Japan 1 trialAll trials in Hamamatsu, Japan